Publications
-
Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up study
Part of BJPsych Open, 2023.
DOI for Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up study Download full text (pdf) of Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up study
-
Application of positron emission tomography in psychiatry-methodological developments and future directions.
Part of Translational Psychiatry, 2022.
DOI for Application of positron emission tomography in psychiatry-methodological developments and future directions. Download full text (pdf) of Application of positron emission tomography in psychiatry-methodological developments and future directions.
-
Modulation of dorsolateral prefrontal cortex functional connectivity after intermittent theta-burst stimulation in depression: combining findings from fNIRS and fMRI
Part of NeuroImage, 2022.
DOI for Modulation of dorsolateral prefrontal cortex functional connectivity after intermittent theta-burst stimulation in depression: combining findings from fNIRS and fMRI Download full text (pdf) of Modulation of dorsolateral prefrontal cortex functional connectivity after intermittent theta-burst stimulation in depression: combining findings from fNIRS and fMRI
-
Suppressing visual hallucinations in an adolescent by occipital transcranial magnetic stimulation: A single-case experimental research design
Part of Neuropsychological rehabilitation (Print), p. 1-10, 2021.
-
Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation
Part of Journal of Psychopharmacology, p. 1536-1541, 2021.
DOI for Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation Download full text (pdf) of Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation
-
Inhibitory and excitatory neurotransmitter systems in depressed and healthy: A positron emission tomography and magnetic resonance spectroscopy study
Part of Psychiatry Research, 2021.
DOI for Inhibitory and excitatory neurotransmitter systems in depressed and healthy: A positron emission tomography and magnetic resonance spectroscopy study Download full text (pdf) of Inhibitory and excitatory neurotransmitter systems in depressed and healthy: A positron emission tomography and magnetic resonance spectroscopy study
-
Response rate and subjective memory after electroconvulsive therapy in depressive disorders with psychiatric comorbidity
Part of Journal of Affective Disorders, p. 276-283, 2021.
DOI for Response rate and subjective memory after electroconvulsive therapy in depressive disorders with psychiatric comorbidity Download full text (pdf) of Response rate and subjective memory after electroconvulsive therapy in depressive disorders with psychiatric comorbidity
-
A blinded validation of the Swedish version of the Clinical Assessment Interview for Negative Symptoms (CAINS)
Part of Nordic Journal of Psychiatry, p. 1-8, 2021.
DOI for A blinded validation of the Swedish version of the Clinical Assessment Interview for Negative Symptoms (CAINS) Download full text (pdf) of A blinded validation of the Swedish version of the Clinical Assessment Interview for Negative Symptoms (CAINS)
-
Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression: a randomized controlled trial
Part of Journal of Affective Disorders, p. 308-315, 2021.
DOI for Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression: a randomized controlled trial Download full text (pdf) of Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression: a randomized controlled trial
-
Unchanged cognitive performance and concurrent prefrontal blood oxygenation after accelerated intermittent theta-burst stimulation in depression: a sham-controlled study
Part of Frontiers in Psychiatry, 2021.
DOI for Unchanged cognitive performance and concurrent prefrontal blood oxygenation after accelerated intermittent theta-burst stimulation in depression: a sham-controlled study Download full text (pdf) of Unchanged cognitive performance and concurrent prefrontal blood oxygenation after accelerated intermittent theta-burst stimulation in depression: a sham-controlled study
-
Lithium influences whole-organism metabolic rate inDrosophila subobscura
Part of Journal of Neuroscience Research, p. 407-418, 2021.
DOI for Lithium influences whole-organism metabolic rate inDrosophila subobscura
-
Ambulatory Heart Rate Variability in Schizophrenia or Depression: Impact of Anticholinergic Burden and Other Factors
Part of Journal of Clinical Psychopharmacology, p. 121-128, 2021.
DOI for Ambulatory Heart Rate Variability in Schizophrenia or Depression: Impact of Anticholinergic Burden and Other Factors Download full text (pdf) of Ambulatory Heart Rate Variability in Schizophrenia or Depression: Impact of Anticholinergic Burden and Other Factors
-
Modulation of the prefrontal blood oxygenation response to intermittent theta-burst stimulation in depression: A sham-controlled study with functional near-infrared spectroscopy
Part of World Journal of Biological Psychiatry, p. 247-256, 2021.
DOI for Modulation of the prefrontal blood oxygenation response to intermittent theta-burst stimulation in depression: A sham-controlled study with functional near-infrared spectroscopy Download full text (pdf) of Modulation of the prefrontal blood oxygenation response to intermittent theta-burst stimulation in depression: A sham-controlled study with functional near-infrared spectroscopy
-
Pain trajectories of dorsomedial prefrontal intermittent theta burst stimulation versus sham treatment in depression
Part of BMC Neurology, 2020.
DOI for Pain trajectories of dorsomedial prefrontal intermittent theta burst stimulation versus sham treatment in depression Download full text (pdf) of Pain trajectories of dorsomedial prefrontal intermittent theta burst stimulation versus sham treatment in depression
-
A register-based approach to identifying treatment-resistant depression: Comparison with clinical definitions
Part of PLOS ONE, 2020.
DOI for A register-based approach to identifying treatment-resistant depression: Comparison with clinical definitions Download full text (pdf) of A register-based approach to identifying treatment-resistant depression: Comparison with clinical definitions
-
Risk of Delayed Discharge and Reoperation of Gastric Bypass Patients with Psychiatric Comorbidity: a Nationwide Cohort Study
Part of Obesity Surgery, p. 2511-2518, 2020.
DOI for Risk of Delayed Discharge and Reoperation of Gastric Bypass Patients with Psychiatric Comorbidity: a Nationwide Cohort Study Download full text (pdf) of Risk of Delayed Discharge and Reoperation of Gastric Bypass Patients with Psychiatric Comorbidity: a Nationwide Cohort Study
-
Intermittent theta burst stimulation over the dorsomedial prefrontal cortex modulates resting-state connectivity in depressive patients: A sham-controlled study
Part of Behavioural Brain Research, 2020.
DOI for Intermittent theta burst stimulation over the dorsomedial prefrontal cortex modulates resting-state connectivity in depressive patients: A sham-controlled study Download full text (pdf) of Intermittent theta burst stimulation over the dorsomedial prefrontal cortex modulates resting-state connectivity in depressive patients: A sham-controlled study
-
Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study
Part of Acta Psychiatrica Scandinavica, p. 74-83, 2020.
DOI for Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study Download full text (pdf) of Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study
-
Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study
Part of Addiction, p. 768-777, 2020.
DOI for Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study Download full text (pdf) of Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study
-
Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study
Part of European Archives of Psychiatry and Clinical Neuroscience, p. 451-459, 2020.
DOI for Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study Download full text (pdf) of Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study
-
All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population
Part of Annals of General Psychiatry, 2019.
DOI for All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population Download full text (pdf) of All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population
-
Suicide Ideation and Behavior as Risk Factors for Subsequent Suicide in Schizophrenia: A Nested Case-Control Study
Part of Journal of Suicide and Life-threatening Behaviour, p. 996-1005, 2019.
-
Monotherapy vs. combination therapy for post mania maintenance treatment: A population based cohort study
Part of European Neuropsychopharmacology, p. 691-700, 2019.
-
Treatment-resistant depression as risk factor for substance use disorders: a nation-wide register-based cohort study
Part of Addiction, p. 1274-1282, 2019.
DOI for Treatment-resistant depression as risk factor for substance use disorders: a nation-wide register-based cohort study Download full text (pdf) of Treatment-resistant depression as risk factor for substance use disorders: a nation-wide register-based cohort study
-
Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Part of Journal of Affective Disorders, p. 674-679, 2018.
-
Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder
Part of Bipolar Disorders, p. 634-646, 2018.
DOI for Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder
-
Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
Part of BMC Psychiatry, 2018.
DOI for Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study Download full text (pdf) of Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
-
Persistent tachycardia in clozapine treated patients: A 24-hour ambulatory electrocardiogram study
Part of Schizophrenia Research, p. 403-406, 2018.
DOI for Persistent tachycardia in clozapine treated patients: A 24-hour ambulatory electrocardiogram study Download full text (pdf) of Persistent tachycardia in clozapine treated patients: A 24-hour ambulatory electrocardiogram study
-
Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections
Part of International Clinical Psychopharmacology, p. 219-224, 2017.
DOI for Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections Download full text (pdf) of Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections
-
Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations
Part of Journal of Affective Disorders, p. 16-23, 2017.
DOI for Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations Download full text (pdf) of Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations
-
Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study
Part of Translational Psychiatry, 2017.
DOI for Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study Download full text (pdf) of Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study
-
Striatal Phosphodiesterase 10A and Thinning of the medial Prefrontal Cortex in Schizophrenia - a PET and MRI study
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. S48-S49, 2016.
-
Re: Pregabalin prescriptions in the United Kingdom - a drug utilisation study of The Health Improvement Network (THIN) primary care database by Asomaning et al.
Part of International journal of clinical practice (Esher), p. 696-696, 2016.
-
Postinjection Delirium Syndrome Associated With Olanzapine Long-Acting Injectable
Part of Journal of Clinical Psychopharmacology, p. 388-389, 2016.
DOI for Postinjection Delirium Syndrome Associated With Olanzapine Long-Acting Injectable
-
Risk factors for suicide among patients with schizophrenia: a cohort study focused on cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid
Part of Neuropsychiatric Disease and Treatment, p. 1711-1714, 2016.
DOI for Risk factors for suicide among patients with schizophrenia: a cohort study focused on cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid Download full text (pdf) of Risk factors for suicide among patients with schizophrenia: a cohort study focused on cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid
-
Suicide risk and antipsychotic side effects in schizophrenia: nested case-control study.
Part of Human Psychopharmacology, p. 341-345, 2016.
DOI for Suicide risk and antipsychotic side effects in schizophrenia: nested case-control study.
-
Diabetes and glucose disturbances in patients with psychosis in Sweden
Part of BMJ Open Diabetes Research & Care, 2015.
DOI for Diabetes and glucose disturbances in patients with psychosis in Sweden
-
Higher mortality after myocardial infarction in patients with severe mental illness: a nationwide cohort study
Part of Journal of Internal Medicine, p. 727-736, 2015.
-
Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder-A nationwide cohort study
Part of Journal of Affective Disorders, p. 204-210, 2015.
-
Suicide in first episode psychosis: A nationwide cohort study
Part of Schizophrenia Research, p. 1-7, 2014.
DOI for Suicide in first episode psychosis: A nationwide cohort study
-
Factors associated with pregabalin dispensing at higher than the approved maximum dose
Part of European Journal of Clinical Pharmacology, p. 197-204, 2014.
DOI for Factors associated with pregabalin dispensing at higher than the approved maximum dose
-
Neuropeptide Y, social function and long-term outcome in schizophrenia
Part of Schizophrenia Research, p. 223-227, 2014.
DOI for Neuropeptide Y, social function and long-term outcome in schizophrenia
-
Psychomotor and cognitive deficits as predictors of 5-year outcome in first-episode schizophrenia
Part of Nordic Journal of Psychiatry, p. 282-288, 2014.
-
Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment
Part of International journal of clinical practice (Esher), p. 104-110, 2014.
-
Medication and suicide risk in schizophrenia: A nested case-control study
Part of Schizophrenia Research, p. 416-420, 2013.
DOI for Medication and suicide risk in schizophrenia: A nested case-control study
-
Antipsychotic Prescription Filling in Patients With Schizophrenia or Schizoaffective Disorder
Part of Journal of Clinical Psychopharmacology, p. 759-765, 2013.
-
A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice
Part of Neuropsychiatric Disease and Treatment, p. 371-377, 2013.
DOI for A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice
-
Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial
Part of International Journal of Neuropsychopharmacology, p. 987-995, 2013.
DOI for Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial Download full text (pdf) of Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial